These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 9813972

  • 1. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G.
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E.
    Cancer; 1995 Dec 01; 76(11):2319-29. PubMed ID: 8635038
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH, Brooks BJ, Case DC, Fishkin E, Jacobson R, Keller AM, Kugler J, Moore J, Silver RT, Storniolo AM, Abels RI, Gordon DS, Nelson R, Larholt K, Bryant E, Rudnick S.
    Cancer J Sci Am; 1995 Dec 01; 1(4):252-60. PubMed ID: 9166485
    [Abstract] [Full Text] [Related]

  • 4. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
    Chiou TJ, Chim YS, Wei CH, Hsieh RK, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov 01; 60(5):229-35. PubMed ID: 9509677
    [Abstract] [Full Text] [Related]

  • 5. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N, Fouda M.
    Hematology; 2007 Dec 01; 12(6):533-41. PubMed ID: 17852440
    [Abstract] [Full Text] [Related]

  • 6. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D, George MJ, Harrison LB.
    Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577
    [Abstract] [Full Text] [Related]

  • 7. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
    Bösze P, Mayer A, Thurzó L, Kiss A, Rák K, Stumpf J.
    Orv Hetil; 1995 Nov 19; 136(47):2567-72. PubMed ID: 8532322
    [Abstract] [Full Text] [Related]

  • 8. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R.
    Sangre (Barc); 1994 Apr 19; 39(2):105-10. PubMed ID: 8059287
    [Abstract] [Full Text] [Related]

  • 9. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 May 19; 88(5):607-12. PubMed ID: 16149676
    [Abstract] [Full Text] [Related]

  • 10. Randomized phase 2 dose-finding study of weekly administration of darbepoetin alpha in anemic patients with lung or ovarian cancer receiving multicycle platinum-containing chemotherapy.
    Ichinose Y, Seto T, Nishiwaki Y, Ohe Y, Yamada Y, Takeda K, Saijo N, Hotta T.
    Jpn J Clin Oncol; 2010 Jun 19; 40(6):521-9. PubMed ID: 20508073
    [Abstract] [Full Text] [Related]

  • 11. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T, Wiedemann GJ, Sack K, Jelkmann W.
    Oncol Rep; 1998 Jun 19; 5(1):81-6. PubMed ID: 9458299
    [Abstract] [Full Text] [Related]

  • 12. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
    Abels RI.
    Semin Oncol; 1992 Jun 19; 19(3 Suppl 8):29-35. PubMed ID: 1615337
    [Abstract] [Full Text] [Related]

  • 13. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
    Sweeney PJ, Nicolae D, Ignacio L, Chen L, Roach M, Wara W, Marcus KC, Vijayakumar S.
    Br J Cancer; 1998 Jun 19; 77(11):1996-2002. PubMed ID: 9667681
    [Abstract] [Full Text] [Related]

  • 14. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM, Antakly MC, Jebara VA.
    J Cardiothorac Vasc Anesth; 2004 Feb 19; 18(1):59-63. PubMed ID: 14973801
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B.
    Exp Hematol; 1990 Dec 19; 18(11):1204-8. PubMed ID: 2226680
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR.
    J Natl Cancer Inst; 1993 May 19; 85(10):801-6. PubMed ID: 8487324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.